| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | RGS9 |
| Uniprot No | O75916 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-674aa |
| 氨基酸序列 | MTIRHQGQQY RPRMAFLQKI EALVKDMQNP ETGVRMQNQR VLVTSVPHAM TGSDVLQWIV QRLWISSLEA QNLGNFIVRY GYIYPLQDPK NLILKPDGSL YRFQTPYFWP TQQWPAEDTD YAIYLAKRNI KKKGILEEYE KENYNFLNQK MNYKWDFVIM QAKEQYRAGK ERNKADRYAL DCQEKAYWLV HRCPPGMDNV LDYGLDRVTN PNEVKVNQKQ TVVAVKKEIM YYQQALMRST VKSSVSLGGI VKYSEQFSSN DAIMSGCLPS NPWITDDTQF WDLNAKLVEI PTKMRVERWA FNFSELIRDP KGRQSFQYFL KKEFSGENLG FWEACEDLKY GDQSKVKEKA EEIYKLFLAP GARRWINIDG KTMDITVKGL KHPHRYVLDA AQTHIYMLMK KDSYARYLKS PIYKDMLAKA IEPQETTKKS STLPFMRRHL RSSPSPVILR QLEEEAKARE AANTVDITQP GQHMAPSPHL TVYTGTCMPP SPSSPFSSSC RSPRKPFASP SRFIRRPSTT ICPSPIRVAL ESSSGLEQKG ECSGSMAPRG PSVTESSEAS LDTSWPRSRP RAPPKARMAL SFSRFLRRGC LASPVFARLS PKCPAVSHGR VQPLGDVGQQ LPRLKSKRVA NFFQIKMDVP TGSGTCLMDS EDAGTGESGD RATEKEVICP WESL |
| 预测分子量 | 76,9 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于RGS9重组蛋白的3篇代表性文献及其摘要概括：
1. **文献名称**: "RGS9. a GTPase Accelerating Protein for Phototransduction, Determines Rod Photoresponse Kinetics"
**作者**: He W. et al.
**摘要**: 该研究通过重组RGS9蛋白与Gβ5的复合体表达，揭示了其在光信号转导中加速G蛋白α亚基(Gαt)的GTP水解活性，从而调控视杆细胞光响应动力学的分子机制。
2. **文献名称**: "Expression and Purification of the RGS9-1/Gβ5 Complex in Insect Cells Using Baculovirus Expression System"
**作者**: Chen C.K. et al.
**摘要**: 研究者利用杆状病毒表达系统成功表达并纯化重组RGS9-1与Gβ5的异源二聚体，验证其与磷酸二酯酶γ亚基(PDEγ)的相互作用，为体外研究RGS9在视觉信号终止中的作用提供工具。
3. **文献名称**: "Structural Basis of RGS9-2 Membrane Anchoring and Its Regulation by Phosphorylation in Striatal Neurons"
**作者**: Masuho I. et al.
**摘要**: 通过重组RGS9-2蛋白的晶体结构解析，阐明其C端棕榈酰化修饰对神经元膜定位的调控，并发现多巴胺受体激活后通过磷酸化影响RGS9-2与G蛋白的相互作用，关联帕金森病病理机制。
注：以上文献信息为领域经典研究示例，实际引用时请核对原文细节及发表年份(如He et al.研究发表于2003年《JBC》)。
RGS9 (Regulator of G Protein Signaling 9) is a member of the RGS protein family, which plays a critical role in modulating G protein-coupled receptor (GPCR) signaling pathways. These proteins act as GTPase-activating proteins (GAPs), accelerating the hydrolysis of GTP bound to the Gα subunit of heterotrimeric G proteins, thereby terminating signaling. RGS9 exists in two major splice variants: RGS9-1. predominantly expressed in the retina and pineal gland, and RGS9-2. found in the striatum and other regions of the central nervous system. Its tissue-specific distribution underscores its diverse physiological roles, including phototransduction in vision and dopamine-mediated signaling in motor control and reward pathways.
Recombinant RGS9 proteins are engineered in vitro using expression systems like *E. coli* or mammalian cell cultures to study its structure-function relationships, regulatory mechanisms, and interactions with GPCR pathways. Research has shown that RGS9-1 is essential for rapid deactivation of phototransduction cascades in retinal rod cells, while RGS9-2 modulates dopamine and opioid receptor signaling, influencing behaviors related to addiction and Parkinson’s disease. Mutations in RGS9 are linked to visual disorders such as bradyopsia and neurodegenerative conditions, making recombinant RGS9 a valuable tool for therapeutic target discovery.
The production of recombinant RGS9 enables biochemical assays, structural studies (e.g., X-ray crystallography), and drug screening to identify modulators of GPCR signaling. Its applications extend to understanding diseases like Leber congenital amaurosis and neuropsychiatric disorders, as well as developing gene therapies or small-molecule drugs targeting RGS9-associated pathways. By dissecting its regulatory roles, recombinant RGS9 contributes to advancing precision medicine for vision and neurological impairments.
×
